Antihypertensive Drugs Market Analysis: By Type (Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, ARBs, Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators Renin Inhibitors); With Forecast (2016-2021)

  • ID: 3920065
  • Report
  • 139 pages
  • IndustryARC
1 of 3
Hypertension is a medical condition in which the blood pressure of an individual is elevated to a level beyond what is the desired level. As a result of this, a number of other conditions such as blood pressure and mental distress can take place. The number of cases of hypertension has grown exponentially in the last decade. Key reason for this has been the drastic change in lifestyle and diet intake. Within individuals working around the clock around different time zones, the required time for an individual to take rest is no longer sufficient. Individuals need plenty of sleep to recover and to be reenergized, however, exactly the opposite takes place with people not getting enough sleep, no exercise, no proper intake of healthy food all of which adds to hypertension in the long run.

Once the condition of hypertension has set in, the drugs which are required to keep this under control may be required for the rest of the individual's life depending on the severity of the condition. In a way, this in itself is a case for the drug developers that there will always be a sustainable demand for the product. Hypertension is a condition which was recognized in the United States much ahead of many of the other regions with the antihypertensive drugs being sold right from day one in this country. There are also cases of a number of individuals taking these drugs as a preventive measure, as many doctors believe that the age group that this affects is slowly increasing in terms of range. Unless there are drastic lifestyle changes and changes in the diets of individuals, hypertension is expected to affect a vast volume of the working population over the next few years, especially in the APAC region with a number of companies and individuals working across different time zones.

Antihypertensive Drugs Market

The Antihypertensive Drugs market can be segmented on the basis of type as:
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Renin Inhibitors

The market has been segmented based on the following geographies:
North America
South America
Middle East

Following are just a few of the companies that are operating in the Antihypertensive Drugs market:
Astra Zeneca Plc
Daiichi Sankyo Company
Johnson & Johnson Ltd
Lupin Limited
Merck & Co
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Antihypertensive Drugs Market Overview
2. Executive Summary
3. Antihypertensive Drugs Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Antihypertensive Drugs Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Antihypertensive Drugs Market
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Antihypertensive Drugs Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Antihypertensive Drugs Market By Type
6.1. Diuretics
6.2. Angiotensin Converting Enzyme (ACE) Inhibitors
6.3. Angiotensin Receptor Blockers (ARBs)
6.4. Calcium Channel Blockers
6.5. Beta Blockers
6.6. Alpha Blockers
6.7. Vasodilators
6.8. Renin Inhibitors
7. Antihypertensive Drugs Market By Geography
7.1. Introduction
7.2. Global Study
7.3. Americas
7.3.1. North America
7.3.2. Brazil
7.3.3. Argentina
7.3.4. Others
7.4. Europe
7.4.1. U.K.
7.4.2. France
7.4.3. Germany
7.4.4. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. Others
7.6. ROW
8. Antihypertensive Drugs Market Entropy
8.1. New Product Launches
8.2. M&As, Collaborations, JVs and Partnerships
9. Company Profiles
9.1. Astra Zeneca Plc
9.2. Daiichi Sankyo Company
9.3. Johnson & Johnson Ltd
9.4. Lupin Limited
9.5. Merck & Co
9.6. Novartis AG
9.7. Pfizer
9.8. Ranbaxy Laboratories Limited
9.9. Sanofi S.A
9.10. Takeda Pharmaceutical Company

"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Bibliography
10.5. Compilation of Expert Insights
10.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown